J Diebold
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
Mazières J, Rothschild S, Bironzo P, Martinez A, Curioni-Fontecedro A, Rosell R, Lattuca-Truc M, Wiesweg M, Besse B, Solomon B, Barlesi F, Schouten R, Wakelee H, Camidge D, Zalcman G, Novello S, Ou S, Milia J, Zhu V, Sabari J, Drilon A, Lusque A, Mhanna L, Cortot A, Mezquita L, Thai A, Mascaux C, Couraud S, Veillon R, Van Den Heuvel M, Neal J, Peled N, Früh M, Ng T, Gounant V, Popat S, Diebold J, Gautschi O. Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry. Ann Oncol 2019
24.05.2019Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
24.05.2019Ann Oncol 2019
Mazières J, Rothschild S I, Bironzo P, Martinez A, Curioni-Fontecedro A, Rosell R, Lattuca-Truc M, Wiesweg M, Besse B, Solomon B, Barlesi F, Schouten R D, Wakelee H, Camidge D R, Zalcman G, Novello S, Ou S I, Milia J, Zhu V W, Sabari J, Drilon A, Lusque A, Mhanna L, Cortot A B, Mezquita L, Thai A A, Mascaux C, Couraud S, Veillon R, Van Den Heuvel M, Neal J, Peled N, Früh Martin, Ng T L, Gounant V, Popat S, Diebold J, Gautschi O
Embolisation der Prostataarterien (PAE) beim lokalisierten Prostata-Karzinom: Eine prospektive, bizentrische Proof-of-Concept Studie
Mordasini L, Hechelhammer L, Diener P, Diebold J, Mattei A, Engeler D, Kim S, Schmid H, Abt D. Embolisation der Prostataarterien (PAE) beim lokalisierten Prostata-Karzinom: Eine prospektive, bizentrische Proof-of-Concept Studie. German Medicale Science, www.egms.de 2018
01.01.2018Embolisation der Prostataarterien (PAE) beim lokalisierten Prostata-Karzinom: Eine prospektive, bizentrische Proof-of-Concept Studie
01.01.2018German Medicale Science, www.egms.de 2018
Mordasini L, Hechelhammer Lukas, Diener PA, Diebold J, Mattei A, Engeler Daniel, Kim SK, Schmid Hans-Peter, Abt Dominik
Prostatic artery embolization in the treatment of localized prostate cancer: a bicentric prospective proof-of-concept study of 12 patients
Mordasini L, Schmid H, Kim S, Muellhaupt G, Engeler D, Mattei A, Diebold J, Diener P, Hechelhammer L, Abt D. Prostatic artery embolization in the treatment of localized prostate cancer: a bicentric prospective proof-of-concept study of 12 patients. J Vasc Interv Radiol 2018; 29:589-97.
01.01.2018Prostatic artery embolization in the treatment of localized prostate cancer: a bicentric prospective proof-of-concept study of 12 patients
01.01.2018J Vasc Interv Radiol 2018; 29:589-97
Mordasini L, Schmid Hans-Peter, Kim SK, Muellhaupt Gautier, Engeler Daniel, Mattei A, Diebold J, Diener PA, Hechelhammer Lukas, Abt Dominik
Prostatic Artery embolization (PAE) beim lokalisierten Prostatakarzinom: Eine prospektive, bizentrische Proof-of-Concept Studie
Mordasini L, Schmid H, Kim S, Muellhaupt G, Engeler D, Mattei A, Diebold J, Diener P, Hechelhammer L, Abt D. Prostatic Artery embolization (PAE) beim lokalisierten Prostatakarzinom: Eine prospektive, bizentrische Proof-of-Concept Studie. Urologe 2018; 57 suppl 1:79.
01.01.2018Prostatic Artery embolization (PAE) beim lokalisierten Prostatakarzinom: Eine prospektive, bizentrische Proof-of-Concept Studie
01.01.2018Urologe 2018; 57 suppl 1:79
Mordasini L, Schmid Hans-Peter, Kim S-Y, Muellhaupt Gautier, Engeler Daniel, Mattei A, Diebold J, Diener Pierre-André, Hechelhammer Lukas, Abt Dominik
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
Feilchenfeldt J, Jochum W, Shoji H, Kushima R, Wagner D, Shimada Y, Cats A, Knuth A, Moch H, Aebi S, Diebold J, Khanfir K, Varga Z, Siano M, Grabsch H, Held U, Schuknecht B, Trip A, Hamaguchi T, Gut P, Balague O, Hofer S. Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2). Br J Cancer 2015; 113:716-21.
27.08.2015Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
27.08.2015Br J Cancer 2015; 113:716-21
Feilchenfeldt J, Jochum Wolfram, Shoji H, Kushima R, Wagner D, Shimada Y, Cats A, Knuth A, Moch H, Aebi S, Diebold J, Khanfir K, Varga Z, Siano Marco, Grabsch H I, Held U, Schuknecht B, Trip A, Hamaguchi T, Gut P, Balague O, Hofer S
Low frequency of colorectal dysplasia in patients with long-standing inflammatory bowel disease colitis: detection by fluorescence endoscopy
Ochsenkühn T, Tillack C, Stepp H, Diebold J, Ott S, Baumgartner R, Brand S, Göke B, Sackmann M. Low frequency of colorectal dysplasia in patients with long-standing inflammatory bowel disease colitis: detection by fluorescence endoscopy. Endoscopy 2006; 38:477-82.
01.05.2006Low frequency of colorectal dysplasia in patients with long-standing inflammatory bowel disease colitis: detection by fluorescence endoscopy
01.05.2006Endoscopy 2006; 38:477-82
Ochsenkühn T, Tillack C, Stepp H, Diebold J, Ott S J, Baumgartner R, Brand Stephan, Göke B, Sackmann M